The Stockholm stock exchange continued to climb on Friday, supported by rising global stock markets. The market's focus was on the Federal Reserve's anticipated interest rate announcement next week, where speculation revolves around whether there will be a 25 or 50 basis point cut. On the domestic front, Dustin issued a profit warning while oil company Tethys Oil received a takeover bid.

At the close, the OMXS30 index was up 0.58 percent to 2,525.18. Shares worth around SEK 13.6 billion were traded on the Stockholm Stock Exchange.

The best performance among the stock exchange's major industrial sectors was energy with a rise of 3.1 percent. Health care lagged behind with a marginal increase.

Among the leading stocks, which are included in the OMXS30 index, SBB B rose 4.4 percent while Electrolux was up 4.1 percent. The worst performers were Sinch and Astra Zeneca, down 1.7 percent each.

IT retailer Dustin issued a profit warning late on Thursday night. Adjusted ebita in the fourth quarter is expected to be 20-40 million kronor compared to 142 million last year. The Factset estimate is SEK 143 million. Net sales are expected to be around SEK 5.0 billion (5.1), compared to analysts' estimates of SEK 5.08 billion. According to the company, market developments have continued to be challenging in the quarter. The share fell 14.6 percent.

The security company Securitas makes a provision of SEK 551 million linked to the US authorities' investigation of Paragon Systems, a subsidiary of the Critical Infrastructure business unit. The investigation primarily relates to allegations of misconduct by certain former employees, as well as Paragon's business dealings with certain subcontractors that started around 2012. The stock dropped 2.1%.

Roc Oil Company, an oil and gas company in Australia, makes a takeover bid for all shares in the oil company Tethys Oil at SEK 58.70 per share. The bid values all shares in Tethys at approximately SEK 1.89 billion. The bid represents a premium of 89.1 percent against Thursday's closing price of SEK 31.05 per share. The share rose 74.6 percent to SEK 54.20.

The pharmaceutical company Moberg Pharma fell 61.1 percent after the announcement that the number of patients who achieved clinical cure in the ongoing North American phase 3 study is lower than the company's expectations. This is based on a subset of patients in the study involving the use of MOB-015 for nail fungus.

Mining company Boliden is in discussions to buy Zinkgruvan in Askersund municipality from the Lundin family's mining giant Lundin Mining, according to Dagens industri. UBS raised Boliden to neutral from sell. Boliden's share rose 1.4 percent.

Investment company Svolder raises its dividend to SEK 1.70 per share from SEK 1.00, an increase of 70 percent. The share rose 2.0 percent.

The industrial company Idun Industrier has carried out a directed share issue of SEK 200 million. The subscription price of SEK 230 per share represents an 8 percent discount to Thursday's closing price. The share fell 7.6 percent.

Welfare technology company Careium lowers its growth forecast for the full year due to delays in infrastructure shifts in the UK and Sweden. Organic growth is now expected to be 5-10 percent, compared with the previous forecast of 12-15 percent. The stock dropped 5 percent.

Further on the analysis front, ABG raised its recommendation on Husqvarna to buy from hold. The share rose 3.6 percent.

Deutsche Bank lowered Astra Zeneca to sell from keep. The share fell 1.7 percent.